Skip to content

FTC Won’t Challenge Amazon’s $3.49 Billion One Medical Deal

  • Agency to issue ‘close at risk’ warning letter on deal
  • FTC still conducting in-depth review of iRobot purchase

The Federal Trade Commission won’t challenge Inc.’s $3.49 billion acquisition of One Medical parent 1Life Healthcare Inc., according to people familiar with the decision, a move that will allow the deal to close later this week.

The agency plans to issue a letter to the companies warning them that the investigation remains open despite the expiration of the statutory deadline for the antitrust review, the people said, speaking anonymously to discuss a pending deal. The FTC also issued a so-called pre-consummation warning letter when the online retail giant purchased film studio Metro-Goldwyn-Mayer last year.